Panayiota G. Michalopoulou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Panayiota G. Michalopoulou has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- Shitij Kapur
Institute of Psychiatry, King's College London, London, UK
4 shared publications Anastasia K. Kalpakidou
Section on Schizophrenia, Imaging and Therapeutics, Institute of Psychiatry, Psychology and Neuroscience, King׳s College London, PO Box 053, 16 De Crespigny Park, London SE5 8AF, UK
2 shared publications- George Konstantakopoulos
First Department of Psychiatry, Eginition Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece
2 shared publications Lefteris Lykouras
Second Department of Psychiatry, Athens University Medical School, Greece
2 shared publications- Shôn Lewis
The University of Manchester, Manchester, UK
2 shared publications - Sukhwinder S. Shergill
Kent and Medway Medical School
2 shared publications
Latest Publications
- Open Access
- 26 September 2025
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 55, e281
Neuromodulation and neural networks in psychiatric disorders: current status and emerging prospects
Psychiatric disorders lead to disability, premature mortality and economic burden, highlighting the urgent need for more effective treatments. The understanding of psychiatric disorders as conditions of large-scale brain networks has created new opportunities for developing targeted, personalised, and mechanism-based therapeutic interventions. Non-invasive brain stimulation (NIBS) techniques, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), can directly modulate dysfunctional neural networks, enabling treatments tailored to the individual’s unique functional network patterns. As NIBS techniques depend on our understanding of the neural networks involved in psychiatric disorders, this review offers a neural network-informed perspective on their applications. We focus on key disorders, including depression, schizophrenia, and obsessive-compulsive disorder, and examine the role of NIBS on cognitive impairment, a transdiagnostic feature that does not respond to conventional treatments. We discuss the advancements in identifying NIBS response biomarkers with the use of electrophysiology and neuroimaging, which can inform the development of optimised, mechanism-based, personalised NIBS treatment protocols. We address key challenges, including the need for more precise, individualised targeting of dysfunctional networks through integration of neurophysiological, neuroimaging and genetic data and the use of emerging techniques, such as low- intensity focused ultrasound, which has the potential to improve spatial precision and target access. We finally explore future directions to improve treatment protocols and promote widespread clinical use of NIBS as a safe, effective and patient-centred treatment for psychiatric disorders.
- 26 September 2025
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 55, e281
Open AccessNeuromodulation and neural networks in psychiatric disorders: current status and emerging prospects
Psychiatric disorders lead to disability, premature mortality and economic burden, highlighting the urgent need for more effective treatments. The understanding of psychiatric disorders as conditions of large-scale brain networks has created new opportunities for developing targeted, personalised, and mechanism-based therapeutic interventions. Non-invasive brain stimulation (NIBS) techniques, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), can directly modulate dysfunctional neural networks, enabling treatments tailored to the individual’s unique functional network patterns. As NIBS techniques depend on our understanding of the neural networks involved in psychiatric disorders, this review offers a neural network-informed perspective on their applications. We focus on key disorders, including depression, schizophrenia, and obsessive-compulsive disorder, and examine the role of NIBS on cognitive impairment, a transdiagnostic feature that does not respond to conventional treatments. We discuss the advancements in identifying NIBS response biomarkers with the use of electrophysiology and neuroimaging, which can inform the development of optimised, mechanism-based, personalised NIBS treatment protocols. We address key challenges, including the need for more precise, individualised targeting of dysfunctional networks through integration of neurophysiological, neuroimaging and genetic data and the use of emerging techniques, such as low- intensity focused ultrasound, which has the potential to improve spatial precision and target access. We finally explore future directions to improve treatment protocols and promote widespread clinical use of NIBS as a safe, effective and patient-centred treatment for psychiatric disorders.
- 1 August 2015
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 25 (8) , 1178-1189
Modafinil combined with cognitive training: Pharmacological augmentation of cognitive training in schizophrenia
- 1 August 2015
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 25 (8) , 1178-1189
Modafinil combined with cognitive training: Pharmacological augmentation of cognitive training in schizophrenia
- 1 March 2015
- Published by Elsevier in Schizophrenia Research
- Vol. 162 (1-3) , 62-63
The effects of a single dose of oxytocin on working memory in schizophrenia
- 1 March 2015
- Published by Elsevier in Schizophrenia Research
- Vol. 162 (1-3) , 62-63
The effects of a single dose of oxytocin on working memory in schizophrenia
- 23 February 2015
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 24 (4) , 477-490
Drugs under early investigation for the treatment of bipolar disorder
Despite the availability of several treatment options for bipolar disorder (BD), patients suffer from chronic, subsyndromal symptoms, quite frequent polarity shifts, cognitive impairment and poor community function. Overall, the current treatment outcomes for BD highlight the need to develop targeted, more effective and safe treatments.
- 23 February 2015
- Published by Informa Healthcare in Expert Opinion on Investigational Drugs
- Vol. 24 (4) , 477-490
Drugs under early investigation for the treatment of bipolar disorder
Despite the availability of several treatment options for bipolar disorder (BD), patients suffer from chronic, subsyndromal symptoms, quite frequent polarity shifts, cognitive impairment and poor community function. Overall, the current treatment outcomes for BD highlight the need to develop targeted, more effective and safe treatments.
- 1 May 2014
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 55 (4) , 1015-1021
Can cognitive deficits differentiate between schizophrenia with and without obsessive–compulsive symptoms?
- 1 May 2014
- Published by Elsevier in Comprehensive Psychiatry
- Vol. 55 (4) , 1015-1021
Can cognitive deficits differentiate between schizophrenia with and without obsessive–compulsive symptoms?
- 22 April 2013
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 23 (8) , 790-798
Treating impaired cognition in schizophrenia: The case for combining cognitive-enhancing drugs with cognitive remediation
- 22 April 2013
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 23 (8) , 790-798
Treating impaired cognition in schizophrenia: The case for combining cognitive-enhancing drugs with cognitive remediation
- Open Access
- 20 December 2011
- Published by Springer Nature in BMC Neuroscience
- Vol. 12 (1) , 128
It's not what you say but the way that you say it: an fMRI study of differential lexical and non-lexical prosodic pitch processing
This study aims to identify the neural substrate involved in prosodic pitch processing. Functional magnetic resonance imaging was used to test the premise that prosody pitch processing is primarily subserved by the right cortical hemisphere.
- 20 December 2011
- Published by Springer Nature in BMC Neuroscience
- Vol. 12 (1) , 128
Open AccessIt's not what you say but the way that you say it: an fMRI study of differential lexical and non-lexical prosodic pitch processing
This study aims to identify the neural substrate involved in prosodic pitch processing. Functional magnetic resonance imaging was used to test the premise that prosody pitch processing is primarily subserved by the right cortical hemisphere.
- 5 July 2010
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 183 (2) , 93-98
The effects of reality distortion syndrome on salient stimuli processing in patients with schizophrenia: An fMRI study
- 5 July 2010
- Published by Elsevier in Psychiatry Research: Neuroimaging
- Vol. 183 (2) , 93-98
The effects of reality distortion syndrome on salient stimuli processing in patients with schizophrenia: An fMRI study